HIV-1 Vpr-Mediated G2 Arrest Involves the DDB1-CUL4AVPRBP E3 Ubiquitin Ligase
Open accessThe DOI matches its Crossref record; 62 of the 62 references it cites were found in a registry or an index.
Abstract
Human immunodeficiency virus type 1 (HIV-1) viral protein R (Vpr) has been shown to cause G2 cell cycle arrest in human cells by inducing ATR-mediated inactivation of p34cdc2, but factors directly engaged in this process remain unknown. We used tandem affinity purification to isolate native Vpr complexes. We found that damaged DNA binding protein 1 (DDB1), viral protein R binding protein (VPRBP), and cullin 4A (CUL4A)--components of a CUL4A E3 ubiquitin ligase complex, DDB1-CUL4A(VPRBP)--were able to associate with Vpr. Depletion of VPRBP by small interfering RNA impaired Vpr-mediated induction of G2 arrest. Importantly, VPRBP knockdown alone did not affect normal cell cycle progression or activation of ATR checkpoints, suggesting that the involvement of VPRBP in G2 arrest was specific to Vpr. Moreover, leucine/isoleucine-rich domain Vpr mutants impaired in their ability to interact with VPRBP and DDB1 also produced strongly attenuated G2 arrest. In contrast, G2 arrest-defective C-terminal Vpr mutants were found to maintain their ability to associate with these proteins, suggesting that the interaction of Vpr with the DDB1-VPRBP complex is necessary but not sufficient to block cell cycle progression. Overall, these results point toward a model in which Vpr could act as a connector between the DDB1-CUL4A(VPRBP) E3 ubiquitin ligase complex and an unknown cellular factor whose proteolysis or modulation of activity through ubiquitination would activate ATR-mediated checkpoint signaling and induce G2 arrest.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Through DCAF1, Vpr interacts with damaged DNA binding protein 1 (DDB1) as part of the Cul4A E3 ubiquitin ligase complex where host proteins recruited by Vpr are ubiquitylated and degraded17–22.”
From HIV-1 Vpr combats the PU.1-driven antiviral response in primary human macrophages (2024) · cites this paper as [21]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Molecular Mechanisms of Mammalian DNA Repair and the DNA Damage Checkpoints
Sancar, A., Lindsey-Boltz, L. A., Ünsal-Kaçmaz, K., & Linn, S. (2004) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.73.011303.073723 · Cited by 3,317 · cited 1×
“Inactivation of cdc2/cyclin by hyperphosphorylation and cytoplasmic retention prevents entry into mitosis before the completion of DNA repair [10,12].”
BackgroundCell cycle checkpoint signaling through the ATM and ATR kinases
Abraham, R. T. (2001) · Genes & Development · doi:10.1101/gad.914401 · Cited by 1,966 · cited 1×
“Inactivation of cdc2/cyclin by hyperphosphorylation and cytoplasmic retention prevents entry into mitosis before the completion of DNA repair [10,12].”
BackgroundThe Tandem Affinity Purification (TAP) Method: A General Procedure of Protein Complex Purification
Puig, O., Caspary, F., Rigaut, G., Rutz, B., Bouveret, E., Bragado-Nilsson, E., Wilm, M., & Séraphin, B. (2001) · Methods · doi:10.1006/meth.2001.1183 · Cited by 1,783 · cited 2×
“For the construction of mammalian expression plasmid psvCMV-TAP, N-terminal TAP tag was first PCR amplified from the pBS1479 plasmid [58] using primers 59-TCTAGACATATGGCAGGCCTTGCGCAAC-39 and 59-GGATCCTCACTACTCGAA-TCGTCATCATCAAGTGCC-39, the last one containing two stop codons between the XhoI and BamHI restriction site…”
MethodWood, R. D., Mitchell, M., Sgouros, J., & Lindahl, T. (2001) · Science · doi:10.1126/science.1056154 · Cited by 1,466 · cited 1×
“The other 120-kDa protein was identified as DDB1, initially considered part of a heterodimeric complex containing damaged DNA binding protein 2 (DDB2), involved in a cellular response to UV-induced DNA damages [24,25].”
BackgroundZufferey, R., Donello, J. E., Trono, D., & Hope, T. J. (1999) · Journal of Virology · doi:10.1128/jvi.73.4.2886-2892.1999 · Cited by 1,014 · cited 1×
“Vectors were titered as described previously with some modifications [61].”
MethodHe, J., Choe, S., Walker, R., Di Marzio, P., Morgan, D. O., & Landau, N. R. (1995) · Journal of Virology · doi:10.1128/jvi.69.11.6705-6711.1995 · Cited by 904 · cited 3×
“the p34cdc2/cyclin B complex [3,4].”
BackgroundGroisman, R., Polanowska, J., Kuraoka, I., Sawada, J.-I., Saijo, M., Drapkin, R., Kisselev, A. F., Tanaka, K., & Nakatani, Y. (2003) · Cell · doi:10.1016/s0092-8674(03)00316-7 · Cited by 744 · cited 3×
“In contrast, DDB1-CUL4ACSA and DDB1-CUL4ADET1-COP1 promote proteolysis of Cockayne syndrome type B gene product (CSB) [26] and c-JUN [41].”
BackgroundInfluentialMolecular architecture and assembly of the DDB1–CUL4A ubiquitin ligase machinery
Angers, S., Li, T., Yi, X., MacCoss, M. J., Moon, R. T., & Zheng, N. (2006) · Nature · doi:10.1038/nature05175 · Cited by 674 · cited 1×
“]. In this complex, DDB1 serves as a scaffold protein presenting substrate to the E3 ubiquitin ligase. The protein is structurally complex and contains three seven-bladed β propellers (βPA, βPB, and βPC) [”
BackgroundJin, J., Arias, E. E., Chen, J., Harper, J. W., & Walter, J. C. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.08.010 · Cited by 632 · cited 6×
“Therefore, given the mutual association of Vpr (Figure 1A, 1C, and 1D therein and [21,22]) and CUL4A (Figure 3B therein and [20]) with VPRBP, these results suggest that Vpr interacts with the DDB1-CUL4A E3 ubiquitin ligase in a single complex and that this association might occur via the intermediary of VPRBP.”
BackgroundMethodInfluentialUV-Induced Ubiquitylation of XPC Protein Mediated by UV-DDB-Ubiquitin Ligase Complex
Sugasawa, K., Okuda, Y., Saijo, M., Nishi, R., Matsuda, N., Chu, G., Mori, T., Iwai, S., Tanaka, K., Tanaka, K., et al. (2005) · Cell · doi:10.1016/j.cell.2005.02.035 · Cited by 576 · cited 1×
“In human cells, DDB1-CUL4A promotes the ubiquitylation of histone 2A [38], histone 3, histone 4 [39], and the xeroderma pigmentosum group C protein (XPC) to regulate their activity [40].”
Background
Cited by
HIV-1 Accessory Proteins—Ensuring Viral Survival in a Hostile Environment
Malim, M. H., & Emerman, M. (2008) · Cell Host & Microbe · doi:10.1016/j.chom.2008.04.008 · Cited by 551
“Moreover, there is precedence with the V protein of paramyxoviruses, which also binds to DDB1, and although the mechanism is entirely different, also causes both cell-cycle arrest and is involved in abrogation of host defense through interference with interferon signaling (Horvath, 2004).”
BackgroundInfluentialBulatov, E., & Ciulli, A. (2015) · Biochemical Journal · doi:10.1042/bj20141450 · Cited by 237
Laguette, N., Brégnard, C., Hue, P., Basbous, J., Yatim, A., Larroque, M., Kirchhoff, F., Constantinou, A., Sobhian, B., & Benkirane, M. (2014) · Cell · doi:10.1016/j.cell.2013.12.011 · Cited by 212
“…of Vpr that may contribute to G2/M arrest have been proposed, yet no consensus has been reached apart from the absolute requirement for the VPRBP-DDB1-CUL4 E3-ligase complex (Belzile et al., 2007; DeHart et al., 2007; Hrecka et al., 2007; Le Rouzic et al., 2007; Tan et al., 2007; Wen et al., 2007).”
APOBEC3A Is a Specific Inhibitor of the Early Phases of HIV-1 Infection in Myeloid Cells
Berger, G., Durand, S., Fargier, G., Nguyen, X.-N., Cordeil, S., Bouaziz, S., Muriaux, D., Darlix, J.-L., & Cimarelli, A. (2011) · PLoS Pathogens · doi:10.1371/journal.ppat.1002221 · Cited by 207
Primate Lentiviral Vpx Commandeers DDB1 to Counteract a Macrophage Restriction
Sharova, N., Wu, Y., Zhu, X., Stranska, R., Kaushik, R., Sharkey, M., & Stevenson, M. (2008) · PLoS Pathogens · doi:10.1371/journal.ppat.1000057 · Cited by 189
Cell Cycle Regulation During Viral Infection
Bagga, S., & Bouchard, M. J. (2014) · Methods in Molecular Biology · doi:10.1007/978-1-4939-0888-2_10 · Cited by 179
Involvement of Lgl and Mahjong/VprBP in Cell Competition
Tamori, Y., Bialucha, C. U., Tian, A.-G., Kajita, M., Huang, Y.-C., Norman, M., Harrison, N., Poulton, J., Ivanovitch, K., Disch, L., et al. (2010) · PLoS Biology · doi:10.1371/journal.pbio.1000422 · Cited by 172
Zhang, Y., Feng, S., Chen, F., Chen, H., Wang, J., McCall, C., Xiong, Y., & Deng, X. W. (2008) · The Plant Cell · doi:10.1105/tpc.108.058891 · Cited by 161
“The human CUL4-DDB1-DCAF1 E3 ubiquitin ligase is recruited by HIV-1 protein Vpr to trigger G2 arrest of HIV-1 infected cells (Belzile et al., 2007; Hrecka et al., 2007; Le Rouzic et al., 2007; Schröfelbauer et al., 2007; Tan et al., 2007; Wen et al., 2007), while the cellular function of DCAF1 and…”
BackgroundRichard, J., Sindhu, S., Pham, T. N. Q., Belzile, J.-P., & Cohen, É. A. (2010) · Blood · doi:10.1182/blood-2009-08-237370 · Cited by 164
Self-citationγ-Glutamylcysteine detoxifies reactive oxygen species by acting as glutathione peroxidase-1 cofactor
Quintana-Cabrera, R., Fernandez-Fernandez, S., Bobo-Jimenez, V., Escobar, J., Sastre, J., Almeida, A., & Bolaños, J. P. (2012) · Nature Communications · doi:10.1038/ncomms1722 · Cited by 162
“Recombinant lentiviruses were generated following a standard protoco”
Kogan, M., & Rappaport, J. (2011) · Retrovirology · doi:10.1186/1742-4690-8-25 · Cited by 205
Goujon, C., Arfi, V., Pertel, T., Luban, J., Lienard, J., Rigal, D., Darlix, J.-L., & Cimarelli, A. (2008) · Journal of Virology · doi:10.1128/jvi.01181-08 · Cited by 142
“Recently, the Cul4-based E3 ubiquitin ligase complex has been identified as being a cofactor in the G2/M cell cycle arrest induced by Vpr ( 6 , 10, 20, 24, 36, 41, 44), and it has been shown to interact via its adaptor DCAF1 with Vpx by yeast two-hybrid (24) or coimmunoprecipitation (40) assays.”
BackgroundResultActivation of the DNA Damage Response by RNA Viruses
Ryan, E., Hollingworth, R., & Grand, R. (2016) · Biomolecules · doi:10.3390/biom6010002 · Cited by 133
“Vpr binding of both Cul4A and DDB1, components of the DDB1-CUL4A-RBX1 E3 ligase complex, via interaction with VPRBP is believed to cause ATR activation and G2 arrest through the ubiquitination of an unknown target [159, 160] .”
BackgroundCerboni, C., Fionda, C., Soriani, A., Zingoni, A., Doria, M., Cippitelli, M., & Santoni, A. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00508 · Cited by 136
Bergamaschi, A., Ayinde, D., David, A., Le Rouzic, E., Morel, M., Collin, G., Descamps, D., Damond, F., Brun-Vezinet, F., Nisole, S., et al. (2009) · Journal of Virology · doi:10.1128/jvi.00187-09 · Cited by 121
“HIV-1 Vpr uses the adaptor function of DCAF1 to assemble with the CUL4A-DDB1 ubiquitin ligase and presumably to divert its activity (3, 8, 18, 26, 38, 46).”
HIV-1 Vpr—a still “enigmatic multitaskerâ€
Guenzel, C. A., Hérate, C., & Benichou, S. (2014) · Frontiers in Microbiology · doi:10.3389/fmicb.2014.00127 · Cited by 120
Pham, T. N. Q., Lukhele, S., Hajjar, F., Routy, J., & Cohen, É. A. (2014) · Retrovirology · doi:10.1186/1742-4690-11-15 · Cited by 116
Self-citationHIV-1 Vpr: Mechanisms of G2 arrest and apoptosis
Andersen, J. L., Rouzic, E. L., & Planelles, V. (2008) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2008.03.015 · Cited by 140
Distinct and overlapping functions of the cullin E3 ligase scaffolding proteins CUL4A and CUL4B
Hannah, J., & Zhou, P. (2015) · Gene · doi:10.1016/j.gene.2015.08.064 · Cited by 110
“In 2007, a deluge of reports described how Vpr binds to DCAF1 and utilizes CRL4DCAF1 to promote G2 arrest and apoptosis (Belzile et al., 2007; Hrecka et al., 2007; Le Rouzic et al., 2007; Schrofelbauer et al., 2007; Wen et al., 2007).”
BackgroundAhn, J., Vu, T., Novince, Z., Guerrero-Santoro, J., Rapic-Otrin, V., & Gronenborn, A. M. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.133181 · Cited by 104
HIV-1 Vpr Triggers Mitochondrial Destruction by Impairing Mfn2-Mediated ER-Mitochondria Interaction
Huang, K. C., Chiang, S., Lin, T., Chiou, S.-H., & Chow, K. (2012) · PLoS ONE · doi:10.1371/journal.pone.0033657 · Cited by 116
Rift Valley fever virus NSs protein functions and the similarity to other bunyavirus NSs proteins
Ly, H. J., & Ikegami, T. (2016) · Virology Journal · doi:10.1186/s12985-016-0573-8 · Cited by 119
Lluesma, S. M., Schaeffer, C., Robert, E. I., Breugel, P. C. V., Leupin, O., Hantz, O., & Strubin, M. (2008) · Hepatology · doi:10.1002/hep.22542 · Cited by 110
HIV-1 Vpr degrades the HLTF DNA translocase in T cells and macrophages
Lahouassa, H., Blondot, M.-L., Chauveau, L., Chougui, G., Morel, M., Leduc, M., Guillonneau, F., Ramirez, B. C., Schwartz, O., & Margottin-Goguet, F. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1600485113 · Cited by 100
The DDB1–DCAF1–Vpr–UNG2 crystal structure reveals how HIV-1 Vpr steers human UNG2 toward destruction
Wu, Y., Zhou, X., Barnes, C. O., DeLucia, M., Cohen, A. E., Gronenborn, A. M., Ahn, J., & Calero, G. (2016) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.3284 · Cited by 97
Vipirinin, a Coumarin-based HIV-1 Vpr Inhibitor, Interacts with a Hydrophobic Region of VPR
Ong, E. B. B., Watanabe, N., Saito, A., Futamura, Y., Galil, K. H. A. E., Koito, A., Najimudin, N., & Osada, H. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.185397 · Cited by 94
Sharma, A., Yilmaz, A., Marsh, K., Cochrane, A., & Boris-Lawrie, K. (2012) · PLoS Pathogens · doi:10.1371/journal.ppat.1002612 · Cited by 93
SAMHD1 Functions and Human Diseases
Coggins, S. A., Mahboubi, B., Schinazi, R. F., & Kim, B. (2020) · Viruses · doi:10.3390/v12040382 · Cited by 98
The Ubiquitin-Conjugating System: Multiple Roles in Viral Replication and Infection
Calistri, A., Munegato, D., Carli, I., Parolin, C., & Palù, G. (2014) · Cells · doi:10.3390/cells3020386 · Cited by 104
“Indeed, Vpr interacts with the cullin4A-DDB1-DCAF1 Ub ligase complex [130, [156] [157] [158] [159] [160] [161] [162] , a binding that is required for the induction of the G2 arrest [163] .”
BackgroundJacquot, G., Rouzic, E. L., David, A., Mazzolini, J., Bouchet, J., Bouaziz, S., Niedergang, F., Pancino, G., & Bénichou, S. (2007) · Retrovirology · doi:10.1186/1742-4690-4-84 · Cited by 103
Limelight on two HIV/SIV accessory proteins in macrophage infection: Is Vpx overshadowing Vpr?
Ayinde, D., Maudet, C., Transy, C., & Margottin-Goguet, F. (2010) · Retrovirology · doi:10.1186/1742-4690-7-35 · Cited by 87
“In 2007, these efforts finally bore fruit; when several studies, including ours, identified VprBP/DCAF1 as a critical host factor in the ability of Vpr to promote cell cycle arrest [80-86].”
McCall, C. M., Miliani de Marval, P. L., Chastain, P. D., Jackson, S. C., He, Y. J., Kotake, Y., Cook, J. G., & Xiong, Y. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.00232-08 · Cited by 83
Mamik, M. K., Asahchop, E. L., Chan, W. F., Zhu, Y., Branton, W. G., McKenzie, B., Cohen, É. A., & Power, C. (2016) · Journal of Neuroscience · doi:10.1523/jneurosci.1287-16.2016 · Cited by 83
“HIV-1 Vpr readily crosses cell membranes and mediates the apoptosis of neurons and other cell types (Muthumani et al., 2002; Jones et al., 2007; Belzile et al., 2007; Patel et al., 2000).”
BackgroundSelf-citationLee, J., & Zhou, P. (2010) · Genes & Cancer · doi:10.1177/1947601910382899 · Cited by 89
The HIV-1 Vpr Protein: A Multifaceted Target for Therapeutic Intervention
González, M. E. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18010126 · Cited by 94
HIV-1 Vpr induces cell cycle arrest and enhances viral gene expression by depleting CCDC137
Zhang, F., & Bieniasz, P. D. (2020) · eLife · doi:10.7554/elife.55806 · Cited by 75
“Rather, HIV-1 Vpr mediated CRL4 recruitment has different biological effects, including G2/M cell-cycle arrest of infected cells (Connor et al., 1995; DeHart et al., 2007; Hrecka et al., 2007; Le Rouzic et al., 2007; Schröfelbauer et al., 2007; Tan et al., 2007; Wen et al., 2007; Jowett et al., 1995; Rogel et al., 199…”
BackgroundHijacking of the Ubiquitin/Proteasome Pathway by the HIV Auxiliary Proteins
Seissler, T., Marquet, R., & Paillart, J. (2017) · Viruses · doi:10.3390/v9110322 · Cited by 91
“In these lineages, the Vpx gene has evolved from Vpr which is present in all HIV and SIV strains and whose main function is the induction of cell cycle arrest [125] [126] [127] [128] [129] .”
BackgroundPathogenic Role of the CRL4 Ubiquitin Ligase in Human Disease
Lee, J., & Zhou, P. (2012) · Frontiers in Oncology · doi:10.3389/fonc.2012.00021 · Cited by 73
“VprBP is also required for cell cycle progression into S phase (Belzile et al., 2007; Hrecka et al., 2007; Le Rouzic et al., 2007; Tan et al., 2007; Wen et al., 2007), but the mechanism of cell cycle regulation and the cellular targets of CRL4VprBP www.frontiersin.org March 2012 | Volume 2 |…”
BackgroundVpr Overcomes Macrophage-Specific Restriction of HIV-1 Env Expression and Virion Production
Mashiba, M., Collins, D. R., Terry, V. H., & Collins, K. L. (2014) · Cell Host & Microbe · doi:10.1016/j.chom.2014.10.014 · Cited by 71
“Previously identified Vpr-dependent phenotypes observed in permissive cell-line systems depend on an interaction with the Cul4A-DDB1-DCAF1 ubiquitin ligase (Ahn et al., 2010; Belzile et al., 2007; Hrecka et al., 2011; Le Rouzic et al., 2007; Wen et al., 2007), which activates the SLX4-endonuclease complex.”
Pertel, T., Reinhard, C., & Luban, J. (2011) · Retrovirology · doi:10.1186/1742-4690-8-49 · Cited by 74
VprBP targets Merlin to the Roc1-Cul4A-DDB1 E3 ligase complex for degradation
Huang, J., & Chen, J. (2008) · Oncogene · doi:10.1038/onc.2008.44 · Cited by 70
“Oncogene (2008) 27, 4056–4064 & 2008 Nature Publishing Group All rights reserved 0950-9232/08 $30.00 www.nature.com/onc unknown (Zhang et al., 2001; Belzile et al., 2007; Hrecka et al., 2007; Le Rouzic et al., 2007; Tan et al., 2007; Wen et al., 2007).”
BackgroundInfluentialEvidence for an Activation Domain at the Amino Terminus of Simian Immunodeficiency Virus Vpx
Gramberg, T., Sunseri, N., & Landau, N. R. (2010) · Journal of Virology · doi:10.1128/jvi.01437-09 · Cited by 69
“In the infected cell, Vpr and Vpx both form complexes with an E3 ubiquitin ligase that is composed of Cullin4a, DDB1, Rbx1, and DCAF1 (6, 20, 24, 31, 38).”
BackgroundBego, M. G., Mercier, J., & Cohen, É. A. (2012) · Journal of Virology · doi:10.1128/jvi.06971-11 · Cited by 70
Self-citationLentivirus Vpr and Vpx accessory proteins usurp the cullin4–DDB1 (DCAF1) E3 ubiquitin ligase
Romani, B., & Cohen, É. A. (2012) · Current Opinion in Virology · doi:10.1016/j.coviro.2012.09.010 · Cited by 63
“The second one encompasses the C-terminal region of the protein, a domain of Vpr that is dispensable for DCAF1 binding, yet is essential for the induction of a G2 arrest [7 ,8 ,9 ,31 ].”
BackgroundSelf-citationWei, W., Guo, H., Han, X., Liu, X., Zhou, X., Zhang, W., & Yu, X.-F. (2012) · Cellular Microbiology · doi:10.1111/j.1462-5822.2012.01835.x · Cited by 73
“The HIV-1 Vpr protein also interacts with DCAF1, which is required for Vpr-induced G2 cell cycle arrest (Battey et al., 2007; Belzile et al., 2007; DeHart et al., 2007; Hrecka et al., 2007; Le Rouzic et al., 2007; Schrofelbauer et al., 2007; Wen et al., 2007).”
BackgroundRomani, B., Shaykh Baygloo, N., Aghasadeghi, M. R., & Allahbakhshi, E. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.641522 · Cited by 63
Human immunodeficiency virus type 1 Vpr: functions and molecular interactions
Romani, B., & Engelbrecht, S. (2009) · Journal of General Virology · doi:10.1099/vir.0.011726-0 · Cited by 88
“The cellcycle G2 arrest provides a replication advantage for the virus, because the transcription level of the provirus is higher during G2 (Belzile et al., 2007; Elder et al., 2001; Goh et al., 1998).”
BackgroundKitayama, H., Miura, Y., Ando, Y., Hoshino, S., Ishizaka, Y., & Koyanagi, Y. (2007) · Journal of Virology · doi:10.1128/jvi.02094-07 · Cited by 62
DeHart, J. L., Bosque, A., Harris, R. S., & Planelles, V. (2008) · Journal of Virology · doi:10.1128/jvi.00377-08 · Cited by 58
Faust, T. B., Binning, J. M., Gross, J. D., & Frankel, A. D. (2017) · Annual Review of Virology · doi:10.1146/annurev-virology-101416-041654 · Cited by 76
Belzile, J.-P., Abrahamyan, L. G., Gérard, F. C. A., Rougeau, N., & Cohen, É. A. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1001080 · Cited by 57
“. The immediate cause of the activation of ATR following Vpr expression has remained elusive but implicates in part the recruitment by Vpr of the host DDB1 (damage DNA binding protein 1; NM_001923)-CUL4A (cullin 4A; NM_003589) E3 ubiquitin ligase complex via a direct binding to the substrate specificity receptor VPRBP…”
BackgroundSelf-citationProteasomal Degradation Machinery: Favorite Target of HIV-1 Proteins
Lata, S., Mishra, R., & Banerjea, A. C. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.02738 · Cited by 71
“However, the exact target of this complex is still unknown (Belzile et al., 2007; DeHart et al., 2007; Hrecka et al., 2007; Schröfelbauer et al., 2007; Tan et al., 2007; Wen et al., 2007).”
BackgroundGhaleh, H. E. G., Bolandian, M., Dorostkar, R., Jafari, A., & Pour, M. F. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110276 · Cited by 61
Vpr-Host Interactions During HIV-1 Viral Life Cycle
Zhao, Y., Li, G., & Bukrinsky, M. (2011) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-011-9261-z · Cited by 65
“In particular, a specific Cullin ubiquitin E3 ligase known as Cul4A-DDB1-DCAF1/ VprBP was found to be associated specifically with this G2 induction process (Belzile et al. 2007; DeHart et al. 2007; Hrecka et al. 2007; Le Rouzic et al. 2007; Schrofelbauer et al. 2007; Tan et al. 2007; Wen et al. 2007).”
Belzile, J.-P., Richard, J., Rougeau, N., Xiao, Y., & Cohen, E. A. (2010) · Journal of Virology · doi:10.1128/jvi.02590-09 · Cited by 49
Self-citationmiRNA-1236 Inhibits HIV-1 Infection of Monocytes by Repressing Translation of Cellular Factor VprBP
Ma, L., Shen, C., Cohen, É. A., Xiong, S., & Wang, J.-H. (2014) · PLoS ONE · doi:10.1371/journal.pone.0099535 · Cited by 49
Self-citationHIV-1 Vpr Protein Inhibits Telomerase Activity via the EDD-DDB1-VPRBP E3 Ligase Complex
Wang, X., Singh, S., Jung, H.-Y., Yang, G., Jun, S., Sastry, K. J., & Park, J.-I. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.416735 · Cited by 47
“As reported previously (26), we observed that Vpr Q65R did not bind to VPRBP in co-immunoprecipitation assays with HeLa cells (Fig.”
BackgroundDNA damage repair machinery and HIV escape from innate immune sensing
Brégnard, C., Benkirane, M., & Laguette, N. (2014) · Frontiers in Microbiology · doi:10.3389/fmicb.2014.00176 · Cited by 57
“Importantly, since the only consensual cellular partner of Vpr for the induction of G2/M arrest is the VPRBP-DDB1-CUL4 E3-ligase complex (Belzile et al., 2007; DeHart et al., 2007; Hrecka et al., 2007; Le Rouzic et al., 2007; Tan et al., 2007; Wen et al., 2007), it was assumed that Vpr would…”
BackgroundVpr and Its Cellular Interaction Partners: R We There Yet?
Fábryová, H., & Strebel, K. (2019) · Cells · doi:10.3390/cells8111310 · Cited by 56
HIV relies on neddylation for ubiquitin ligase-mediated functions
Nekorchuk, M. D., Sharifi, H. J., Furuya, A. K. M., Jellinger, R. M., & de Noronha, C. M. C. (2013) · Retrovirology · doi:10.1186/1742-4690-10-138 · Cited by 47
“HIV-1 Vpr also promotes G2 cell cycle arrest though interaction with the CRL4 ubiquitin ligase complex [17,22,36-39].”
BackgroundCRL4–DDB1–VPRBP ubiquitin ligase mediates the stress triggered proteolysis of Mcm10
Kaur, M., Khan, M. M., Kar, A., Sharma, A., & Saxena, S. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks366 · Cited by 53
Fregoso, O. I., & Emerman, M. (2016) · mBio · doi:10.1128/mbio.01433-16 · Cited by 53
Gonçalves, A. B., Hasselbalch, S. K., Joensen, B. B., Patzke, S., Martens, P. C., Ohlsen, S. K., Quinodoz, M., Nikopoulos, K., Suleiman, R., Jeppesen, M. P. D., et al. (2021) · eLife · doi:10.7554/elife.63731 · Cited by 47
Proliferation defects and genome instability in cells lacking Cul4A
Kopanja, D., Stoyanova, T. I., Okur, M. N., Huang, E. W., Bagchi, S., & Raychaudhuri, P. (2009) · Oncogene · doi:10.1038/onc.2009.86 · Cited by 47
“In addition to p27Kip1 and p53, Cul4A has been implicated also in the proteolysis of HOXA9, the c-Jun proteins and several viral proteins (Wertz et al., 2004; Zhang et al., 2003; Ulane and Horvath, 2002; Belzile et al., 2007; Bergametti et al., 2002).”
BackgroundHIV-1 Vpr counteracts HLTF-mediated restriction of HIV-1 infection in T cells
Yan, J., Shun, M.-C., Zhang, Y., Hao, C., & Skowroński, J. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1818401116 · Cited by 52
The HIV1 Protein Vpr Acts to Enhance Constitutive DCAF1-Dependent UNG2 Turnover
Wen, X., Casey Klockow, L., Nekorchuk, M., Sharifi, H. J., & de Noronha, C. M. C. (2012) · PLoS ONE · doi:10.1371/journal.pone.0030939 · Cited by 41
SLX4-SLX1 Protein-independent Down-regulation of MUS81-EME1 Protein by HIV-1 Viral Protein R (Vpr)
Zhou, X., DeLucia, M., & Ahn, J. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.721183 · Cited by 43
“We thus tested a Vpr mutant, R80A, that is deficient in inducing cell cycle arrest (10, 22, 38, 39).”
BackgroundMethodResultInfluentialGendron, K., Charbonneau, J., Dulude, D., Heveker, N., Ferbeyre, G., & Brakier‐Gingras, L. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkm906 · Cited by 50
“Indeed, the HIV-1 Vpr protein is capable of inducing G2 arrest in cultured CD4+ T cells (48, 49 and references therein), and, during such arrest, cap-dependent translation initiation is severely impaired (50) .”
BackgroundMultifaceted activity of HIV Vpr/Vpx proteins: the current view of their virological functions
Fujita, M., Otsuka, M., Nomaguchi, M., & Adachi, A. (2010) · Reviews in Medical Virology · doi:10.1002/rmv.636 · Cited by 42
The Cullin-RING E3 Ubiquitin Ligase CRL4−DCAF1 Complex Dimerizes via a Short Helical Region in DCAF1
Ahn, J., Novince, Z., Concel, J., Byeon, C.-H., Makhov, A. M., Byeon, I.-J. L., Zhang, P., & Gronenborn, A. M. (2011) · Biochemistry · doi:10.1021/bi101749s · Cited by 41
Xiao, Y., Chen, G., Richard, J., Rougeau, N., Li, H., Seidah, N. G., & Cohen, É. A. (2007) · Virology · doi:10.1016/j.virol.2007.10.036 · Cited by 47
“Indeed the degree of G2 arrest induced by Vpr (1–86) was similar to that of Vpr R80A, a well characterized G2 arrest-defective Vpr mutant (Belzile et al., 2007).”
BackgroundSelf-citationJacquot, G., Rouzic, E. L., Maidou-Peindara, P., Maizy, M., Lefrère, J., Daneluzzi, V., Monteiro-Filho, C. M., Hong, D., Planelles, V., Morand‐Joubert, L., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0007514 · Cited by 42
“, Vpr-induced G2-arrest, which is consequent to its interaction with the DCAF1 subunit of the Cul4a/DDB1 E3 ubiquitin ligase”
BackgroundVpr and Its Interactions with Cellular Proteins
Planelles, V., & Bénichou, S. (2009) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-02175-6_9 · Cited by 51
Li, D., Lopez, A., Sandoval, C., Doyle, R. N., & Fregoso, O. I. (2020) · mBio · doi:10.1128/mbio.00940-20 · Cited by 47
“However, HIV-1 L64A/HIV-2 L69A was still able to recruit the DCAF1 adaptor protein, though at a slightly lower level than wild type Vpr (Fig.”
BackgroundInfluentialVassena, L., Giuliani, E., Matusali, G., Cohen, É. A., & Doria, M. (2013) · Journal of General Virology · doi:10.1099/vir.0.055541-0 · Cited by 41
“Next, cell-surface PVR levels were monitored in cells expressing Vpr mutants that lost the capacity to interact with UNG2 DNA repair enzyme (VprW54R), with DCAF-1 and E3 ligase (VprQ65R), or affected a putative activation domain without inhibiting DCAF-1 binding and E3 ligase recruitment (VprR80A) (Belzile et al., 200…”
BackgroundResultInfluentialSelf-citationThe functions of the HIV1 protein Vpr and its action through the DCAF1·DDB1·Cullin4 ubiquitin ligase
Casey, L., Wen, X., & de Noronha, C. M. C. (2010) · Cytokine · doi:10.1016/j.cyto.2010.02.018 · Cited by 44
Assembly with the Cul4A-DDB1DCAF1 Ubiquitin Ligase Protects HIV-1 Vpr from Proteasomal Degradation
Rouzic, E. L., Morel, M., Ayinde, D., Belaïdouni, N., Letienne, J., Transy, C., & Margottin-Goguet, F. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m710298200 · Cited by 39
Mannose receptor is an HIV restriction factor counteracted by Vpr in macrophages
Lubow, J., Virgilio, M. C., Merlino, M., Collins, D. R., Mashiba, M., Peterson, B. G., Lukic, Z., Painter, M. M., Gomez-Rivera, F., Terry, V., et al. (2020) · eLife · doi:10.7554/elife.51035 · Cited by 35
“This complex is required for most of the known functions of Vpr, including: disruption of the cell cycle, disruption of cellular DNA repair pathways in dividing cells (Belzile et al., 2007; Hrecka et al., 2007; Le Rouzic et al., 2007; Wen et al., 2007; Lahouassa et al., 2016; Wu et al., 2016; Zhou et al., 2016) and tr…”
BackgroundWang, Q., & Su, L. (2019) · mBio · doi:10.1128/mbio.01344-19 · Cited by 34
“Vpr has two widely studied activities: one is its ability to induce G2 cell cycle arrest, and the other is to increase HIV-1 replication in macrophages (32, 33).”
Maudet, C., Sourisce, A., Dragin, L., Lahouassa, H., Rain, J., Bouaziz, S., Ramírez, B. C., & Margottin-Goguet, F. (2013) · PLoS ONE · doi:10.1371/journal.pone.0077320 · Cited by 37
“A second mutant, VprS79A, which has lost its ability to arrest the cell cycle in G2 [15,18], still interacted with both sZIP and ZIP in vivo (Figure 4C) and induced their degradation (Figure 4A and Figure S4A, compare lanes 1, 2 and 4).”
BackgroundWei, W., Guo, H., Liu, X., Zhang, H., Qian, L., Luo, K., Markham, R. B., & Yu, X. (2013) · Journal of Virology · doi:10.1128/jvi.02568-13 · Cited by 39
Virion-Associated Vpr Alleviates a Postintegration Block to HIV-1 Infection of Dendritic Cells
Miller, C. M., Akiyama, H., Agosto, L. M., Emery, A., Ettinger, C. R., Swanstrom, R. I., Henderson, A. J., & Gummuluru, S. (2017) · Journal of Virology · doi:10.1128/jvi.00051-17 · Cited by 38
Virion encapsidated HIV-1 Vpr induces NFAT to prime non-activated T cells for productive infection
Höhne, K., Businger, R., Nuffel, A. V., Bolduan, S., Koppensteiner, H., Baeyens, A., Vermeíre, J., Malatinková, E., Verhasselt, B., & Schindler, M. (2016) · Open Biology · doi:10.1098/rsob.160046 · Cited by 39
Augustine, T., Chaudhary, P., Gupta, K., Islam, S., Ghosh, P., Santra, M. K., & Mitra, D. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.765842 · Cited by 36
“G2/M phase arrest is brought about by two viral proteins, Vpr (34, 35) and Vif (36).”
BackgroundBarnitz, R. A., Wan, F., Tripuraneni, V., Bolton, D. L., & Lenardo, M. J. (2010) · Journal of Virology · doi:10.1128/jvi.02273-09 · Cited by 36
“analysis confirmed equivalent delivery and stability of wild type (medium dose; WT [3]) and mutant (S79A [5] and R80A”
BackgroundStructural alteration of DNA induced by viral protein R of HIV-1 triggers the DNA damage response
Iijima, K., Kobayashi, J., & Ishizaka, Y. (2018) · Retrovirology · doi:10.1186/s12977-018-0391-8 · Cited by 34
Proteo-Transcriptomic Dynamics of Cellular Response to HIV-1 Infection
Golumbeanu, M., Desfarges, S., Hernandez, C., Quadroni, M., Rato, S., Mohammadi, P., Telenti, A., Beerenwinkel, N., & Ciuffi, A. (2019) · Scientific Reports · doi:10.1038/s41598-018-36135-3 · Cited by 39
DCAF1 controls T-cell function via p53-dependent and -independent mechanisms
Guo, Z., Kong, Q., Liu, C., Zhang, S., Zou, L., Yan, F., Whitmire, J. K., Xiong, Y., Chen, X., & Wan, Y. Y. (2016) · Nature Communications · doi:10.1038/ncomms10307 · Cited by 36
Vpr Enhances Tumor Necrosis Factor Production by HIV-1-Infected T Cells
Roesch, F., Richard, L., Rua, R., Porrot, F., Casartelli, N., & Schwartz, O. (2015) · Journal of Virology · doi:10.1128/jvi.02098-15 · Cited by 37
“Cell cycle arrest (102) (56) (55, 104) (59) (103) (56) (102)”
SAMHD1 … and Viral Ways around It
Deutschmann, J., & Gramberg, T. (2021) · Viruses · doi:10.3390/v13030395 · Cited by 34
HIV-1 Vpr Induces Widespread Transcriptomic Changes in CD4 + T Cells Early Postinfection
Bauby, H., Ward, C. C., Hugh-White, R., Swanson, C. M., Schulz, R., Goujon, C., & Malim, M. H. (2021) · mBio · doi:10.1128/mbio.01369-21 · Cited by 39
Caspase cleavage of gasdermin E causes neuronal pyroptosis in HIV-associated neurocognitive disorder
Fernandes, J. P., Branton, W. G., Cohen, É. A., Koopman, G., Kondova, I. I., Gelman, B. B., & Power, C. (2023) · Brain · doi:10.1093/brain/awad375 · Cited by 33
Self-citationSakai, K., Barnitz, R. A., Chaigne-Delalande, B., Bidère, N., & Lenardo, M. J. (2011) · Virology Journal · doi:10.1186/1743-422x-8-219 · Cited by 30
Sensing of HIV-1 Infection in Tzm-bl Cells with Reconstituted Expression of STING
Trotard, M., Tsopoulidis, N., Tibroni, N., Willemsen, J., Binder, M., Ruggieri, A., & Fackler, O. (2015) · Journal of Virology · doi:10.1128/jvi.02966-15 · Cited by 30
Cellular Cullin RING Ubiquitin Ligases: Druggable Host Dependency Factors of Cytomegaloviruses
Becker, T., Le‐Trilling, V. T. K., & Trilling, M. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20071636 · Cited by 31
“Well-known examples of viral exploitation of DDB1 and/or CRLs include the hepatitis B virus (HBV) protein HBx [84, [89] [90] [91] [92] , the HIV-1-and HIV-2-encoded protein Vpr [93] [94] [95] [96] [97] [98] [99] [100] [101] [102] , HIV-2 Vpx [103] [104] [105] [106] [107] [108] [109] , parainfluenza virus (PIV) V prote…”
Wang, H., Guo, H., Su, J., Rui, Y., Zheng, W., Gao, W., Zhang, W., Li, Z., Liu, G., Markham, R. B., et al. (2017) · Journal of Virology · doi:10.1128/jvi.00225-17 · Cited by 29
de Silva, S., Planelles, V., & Wu, L. J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0035385 · Cited by 37
Power, C., Hui, E., Vivithanaporn, P., Acharjee, S., & Polyak, M. J. (2011) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-011-9310-7 · Cited by 28
HIV-1 Vpr Redirects Host Ubiquitination Pathway
Arora, S., Verma, S. K., & Banerjea, A. C. (2014) · Journal of Virology · doi:10.1128/jvi.00619-14 · Cited by 27
“, induction of G2 cell cycle arrest (18, 38) and transcriptional coactivation of viral and host genes (39).”
BackgroundAccessories to the crime: Recent advances in HIV accessory protein biology
Gramberg, T., Sunseri, N., & Landau, N. R. (2009) · Current HIV/AIDS Reports · doi:10.1007/s11904-009-0006-z · Cited by 29
Metadata
- Authors
- Belzile, J.-P., Duisit, G., Rougeau, N., Mercier, J., Finzi, A., & Cohen, É. A.
- Affiliations
- Montreal Clinical Research Institute (CA)
- Université de Montréal (CA)
- Corresponding author
- Cohen, Éric A
- Venue
- PLoS Pathogens
- Publisher
- Public Library of Science (PLoS)
- Published
- 2007-07-13
- Volume
- 3
- Issue
- 7
- Pages
- e85
- ISSN
- 1553-7366 (ISSN-L)
- 1553-7374
- PMC
- PMC1914068
- OpenAlex
- W2010577903
- Cited by
- 189
- References
- 62
- Citations by year
- 2026: 3 · 2025: 3 · 2024: 9 · 2023: 5 · 2022: 2 · 2021: 9 · 2020: 8 · 2019: 11 · 2018: 7 · 2017: 8 · 2016: 12 · 2015: 8 · 2014: 17 · 2013: 8 · 2012: 18
- FWCI
- 6.23
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS Pathogens (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
- Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Keywords
- HIV-1 Vpr, G2 cell cycle arrest, VprBP, ubiquitination, viral protein-protein interaction
- MeSH terms
- Animals, Cells, Cultured, DNA-Binding Proteins, Goats, Humans, Rabbits, Transfection, Virus Replication, HIV-1, Gene Expression Regulation, Viral, G2 Phase, Two-Hybrid System Techniques, Gene Silencing, RNA Interference, RNA, Small Interfering, Ubiquitin-Protein Ligases, Cullin Proteins, Mice, vpr Gene Products, Human Immunodeficiency Virus
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.